Literature DB >> 14616397

Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab.

M Goebeler, S Herzog, E-B Bröcker, D Zillikens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14616397     DOI： 10.1046/j.1365-2133.2003.05580.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

Review 1.  T cells and B cells in the pathogenesis of systemic sclerosis: recent insights and therapeutic opportunities.

Authors:  Francesco Del Galdo; Carol M Artlett
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

Review 2.  Rituximab in treatment-resistant autoimmune blistering skin disorders.

Authors:  Enno Schmidt; Eva-Bettina Bröcker; Matthias Goebeler
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

3.  [Successful treatment of pemphigus foliaceus with rituximab. Report of 3 cases].

Authors:  M Alter; M Wittmann; B Völker; A Kapp; T Werfel; R Gutzmer
Journal:  Hautarzt       Date:  2009-09       Impact factor: 0.751

Review 4.  Refractory pemphigus foliaceus and Behçet's disease successfully treated with tocilizumab.

Authors:  Francesco Caso; Luca Iaccarino; Silvano Bettio; Francesca Ometto; Luisa Costa; Leonardo Punzi; Andrea Doria
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 5.  Current Clinical Trials in Pemphigus and Pemphigoid.

Authors:  Kentaro Izumi; Katja Bieber; Ralf J Ludwig
Journal:  Front Immunol       Date:  2019-05-03       Impact factor: 7.561

Review 6.  Off-Label Uses of Rituximab in Dermatology.

Authors:  Connor Cole; Kyle T Amber
Journal:  Curr Dermatol Rep       Date:  2022-10-06

7.  Effectiveness and side effects of anti-CD20 therapy for autoantibody-mediated blistering skin diseases: A comprehensive survey of 71 consecutive patients from the Initial use to 2007.

Authors:  Jennifer D Peterson; Lawrence S Chan
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

8.  Severe multi-resistant pemphigus vulgaris: prolonged remission with a single cycle of rituximab.

Authors:  Isabela Soubhia Corral; Thais Helena Proença de Freitas; Renata Telles Rudge de Aquino; Daniella Abbruzzini S Koller; Maria Elisa Ruffolo Magliari; Helena Muller
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.